Fenwick Represents Synfini in $8.9M Series Seed Funding

Fenwick represented Synfini, an AI-driven chemistry automation company, in its $8.9 million Series Seed financing. The round was led by JSL Health Capital with participation from early-stage investors.

Synfini will use the funds to provide resources necessary for further development, to scale operations, and to expand customer collaborations. Additional information can be obtained here.

The Fenwick transaction team was led by corporate partner Sam Angus and included associates John Clancy, Seena Razavi, and Molly Kearnan.